International Clinical Trial: Efficacy and Safety of Chemotherapy Combined with Sintilimab in Neoadjuvant Treatment of Middle and Low Rectal Cancer: A Single-Center, Randomized Controlled, Phase ? Clinical Trial

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131516) titled 'Efficacy and Safety of Chemotherapy Combined with Sintilimab in Neoadjuvant Treatment of Middle and Low Rectal Cancer: A Single-Center, Randomized Controlled, Phase ? Clinical Trial' on Sept. 3.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Xijing Hospital of the Fourth Military Medical University of the Chinese People's Liberation Army

Condition: middle and low rectal cancer

Intervention: experimental group:Perioperative XELOX Chemotherapy Regimen Combined with Sintilimab Injection. Sintilimab Injection, 200 mg, D1, Q3W x4 cycles XELOX x4 cycles.

Recruitment Status: Recruiting...